Gemtuzumab (Anti-Siglec-3 / CD33)

Gemtuzumab (Anti-Siglec-3 / CD33) a monoclonal antibody targeting CD33 antigen, which present on leukemic myeloblasts of acute myeloid leukemia (AML). It can be used for the research of acute myeloid leukemia.MW :145.22 KD.

• Supplier: Selleck Chemicals
• Product #: A3161
• Sku #: A3161-1mg